The Centers for Disease Control and Prevention (CDC) have recently published their annual progress report on healthcare-associated infections on January 29th. The report indicates substantial decreases in hospital-related infections in the year gone by. The salient findings of the report include a significant 11% decrease in hospital-onset Clostridioides difficile, commonly known as C. difficile, infection.…
Cayuga Medical Center, located in Ithaca, N.Y., has recently shared some outstanding news in regard to their dedication to infection prevention. The hospital has accomplished an extraordinary feat of going over 1,200 continuous days without a single reported Central Line-Associated Bloodstream Infection (CLABSI). CLABSI, a potentially serious infection that transpires when bacteria infiltrates the bloodstream…
Teleflex Incorporated, a recognized global leader in medical technologies, recently conducted a multinational study on its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs). The study results lend substantial clinical validation to the product, revealing an impressive 70.5% reduction in CLABSI (central line-associated bloodstream infections) - a percentage derived from a robust sample size of more than…
A considerable accomplishment has been recently recognized among a significant number of hospitals across the United States. According to the most recent update from the Healthcare-Associated Infections (HAI) dataset presented by the Centers for Medicare & Medicaid Services (CMS), no less than 339 American hospitals have successfully achieved a zero rate of central line-associated bloodstream…
Central line-associated bloodstream infections (CLABSI) are a significant concern within the healthcare sector. These preventable hospital-acquired infections can lead to prolonged hospital stays, increased healthcare costs, and heightened morbidity and mortality rates. In a crucial step towards improving patient safety and enabling early intervention strategies, innovative dynamic prediction models are being developed for continuous CLABSI…
The burgeoning issue of central line-associated bloodstream infection (CLABSI) rates recorded in the Intensive Care Units (ICUs) of China has been the subject of considerable debate for substantial reasons. A recent study, aimed at providing a precise evaluation of these rates, embraced a meta-analysis approach encompassing 23 studies sourced from various platforms that include PubMed,…
The Department of Health and Human Services has officially announced exciting news for acute care hospitals. The Agency for Healthcare Research and Quality (AHRQ) is launching a complimentary 9-month program which will commence this July, with the aim of implementing strategies to diminish Central Line-Associated Bloodstream Infections (CLABSIs). The program presents an excellent opportunity for…
The year 2021 brought a considerable public health predicament for Saudi Arabia as it grappled with a startling prevalence of Central line-associated bloodstream infections (CLABSI) in adult Intensive Care Units (ICUs). Fast forward to the present, the Kingdom has successfully navigated this crisis, achieving a 48.8% reduction in CLABSI incidents through the implementation of a…
Central line-associated bloodstream infections (CLABSI), ubiquitous yet preventable hospital-acquired infections, contribute to significant morbidity and healthcare expenditure, necessitating rigorous scrutiny. Recently, a study has delved into the disparities in CLABSI outcomes based on variables such as race, ethnicity, and hospital attributes. This study used data from the National Inpatient Sample (NIS) database from 2016 to…
New data presented at the Infusion Nurses Society Annual Scientific Meeting showcased the significant impact of MIMIX® hydrophilic biomaterial (HBM), created by Access Vascular, Inc. (AVI), on bacterial adhesion and thrombus accumulation in peripherally inserted central catheters (PICCs) and midline catheters. Compared to conventional catheters, AVI's biomaterial demonstrated compelling potential in reducing the incidence and…